JCR Pharmaceuticals Co., Ltd.
4552.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥78,739,534 | ¥62,506,411 | ¥59,892,024 | ¥74,809,773 |
| - Cash | ¥15,621,000 | ¥13,180,000 | ¥13,196,000 | ¥15,513,000 |
| + Debt | ¥40,105,000 | ¥40,105,000 | ¥38,105,000 | ¥32,392,000 |
| Enterprise Value | ¥103,223,534 | ¥89,431,411 | ¥84,801,024 | ¥91,688,773 |
| Revenue | ¥12,793,000 | ¥8,569,000 | ¥7,192,000 | ¥9,223,000 |
| % Growth | 49.3% | 19.1% | -22% | – |
| Gross Profit | ¥10,788,000 | ¥6,174,000 | ¥2,818,000 | ¥6,546,000 |
| % Margin | 84.3% | 72.1% | 39.2% | 71% |
| EBITDA | ¥4,088,000 | ¥67,000 | -¥5,179,000 | ¥739,250 |
| % Margin | 32% | 0.8% | -72% | 8% |
| Net Income | ¥2,256,000 | -¥546,000 | -¥4,183,000 | ¥115,000 |
| % Margin | 17.6% | -6.4% | -58.2% | 1.2% |
| EPS Diluted | 18.5 | -4.48 | -33.8 | 0.94 |
| % Growth | 512.9% | 86.7% | -3,695.7% | – |
| Operating Cash Flow | – | ¥0 | ¥0 | ¥0 |
| Capital Expenditures | – | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | – | ¥0 | ¥0 | ¥0 |